Hsin-an A. Hou

No. 1, Changde Street
TPQ 10048, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 162 publications

Erratum: Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

Erratum: Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 30, 2026

Response to "Comment on 'Consensus of the hematology society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)'".

Response to "Comment on 'Consensus of the hematology society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)'".

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: June 08, 2026

Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 02, 2026

Clinicomolecular features and clonal evolution of KMT2A-PTD AML: prognostic impact of concurrent FLT3-ITD under 2022 ELN risk stratification.

Clinicomolecular features and clonal evolution of KMT2A-PTD AML: prognostic impact of concurrent FLT3-ITD under 2022 ELN risk stratification.

Journal: Blood cancer journal
Published: May 24, 2026

Response to Comment on: "Prognostic implications of myelodysplasia-related gene mutations in NPM1-mutated acute myeloid leukemia: a systematic review and meta-analysis".

Response to Comment on: "Prognostic implications of myelodysplasia-related gene mutations in NPM1-mutated acute myeloid leukemia: a systematic review and meta-analysis".

Journal: Haematologica
Published: March 18, 2026

Real-world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutations.

Real-world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutations.

Journal: Blood research
Published: January 01, 2026

An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study.

An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study.

Journal: Cancer science
Published: December 26, 2025

Outcomes of patients with R/R FLT3mut+ AML treated with maintenance gilteritinib therapy after hematopoietic stem cell transplantation.

Outcomes of patients with R/R FLT3mut+ AML treated with maintenance gilteritinib therapy after hematopoietic stem cell transplantation.

Journal: Leukemia research
Published: November 13, 2025

Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus Classification.

Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus Classification.

Journal: Blood cancer journal
Published: September 09, 2025

Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromes.

Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromes.

Journal: Blood research
Published: September 03, 2025

Association between mean corpuscular volume and cognitive function in community-dwelling older adults: An 8-year cohort study.

Association between mean corpuscular volume and cognitive function in community-dwelling older adults: An 8-year cohort study.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: August 17, 2025

Consensus of the Hematology Society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH).

Consensus of the Hematology Society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH).

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: August 16, 2025
Showing 1-12 of 162

Last Updated: 09/26/2026